logo
Dozen Of Kids, Adults Die Of Starvation In Gaza As Hunger Surges

Dozen Of Kids, Adults Die Of Starvation In Gaza As Hunger Surges

NDTV6 days ago
Deir Al-Balah:
Five starving children at a Gaza City hospital were wasting away, and nothing the doctors tried was working. The basic treatments for malnourishment that could save them had run out under Israel's blockade. The alternatives were ineffective. One after another, the babies and toddlers died over four days.
In greater numbers than ever, children hollowed up by hunger are overwhelming the Patient's Friends Hospital, the main emergency center for malnourished kids in northern Gaza.
The deaths last weekend also marked a change: the first seen by the center in children who had no preexisting conditions. Symptoms are getting worse, with children too weak to cry or move, said Dr. Rana Soboh, a nutritionist. In past months, most improved, despite supply shortages, but now patients stay longer and don't get better, she said.
"There are no words in the face of the disaster we are in. Kids are dying before the world ... There is no uglier and more horrible phase than this," said Soboh, who works with the US-based aid organisation Medglobal, which supports the hospital.
This month, the hunger that has been building among Gaza's more than 2 million Palestinians passed a tipping point into accelerating death, aid workers and health staff say. Not only children - usually the most vulnerable - are falling victim under Israel's blockade since March, but also adults.
In the past three weeks, at least 48 people died of causes related to malnutrition, including 28 adults and 20 children, the Gaza Health Ministry said Thursday. That's up from 10 children who died in the five previous months of 2025, according to the ministry.
The U.N reports similar numbers. The World Health Organization said Wednesday it has documented 21 children under 5 who died of causes related to malnutrition in 2025. The UN humanitarian office, OCHA, said Thursday at least 13 children's deaths were reported in July, with the number growing daily.
"Humans are well developed to live with caloric deficits, but only so far," said Dr. John Kahler, Medglobal's co-founder and a pediatrician who volunteered twice in Gaza during the war. "It appears that we have crossed the line where a segment of the population has reached their limits"
"This is the beginning of a population death spiral," he said.
The UN's World Food Program says nearly 100,000 women and children urgently need treatment for malnutrition. Medical workers say they have run out of many key treatments and medicines.
Israel, which began letting in only a trickle of supplies the past two months, has blamed Hamas for disrupting food distribution. The UN counters that Israel, which has restricted aid since the war began, simply has to allow it to enter freely.
The Patient's Friends Hospital overflows with parents bringing in scrawny children - 200 to 300 cases a day, said Soboh.
On Wednesday, staff laid toddlers on a desk to measure the circumference of their upper arms - the quickest way to determine malnutrition. In the summer heat, mothers huddled around specialists, asking for supplements. Babies with emaciated limbs screamed in agony. Others lay totally silent.
The worst cases are kept for up to two weeks at the center's 10-bed ward, which this month has had up to 19 children at a time. It usually treats only children under 5, but began taking some as old as 11 or 12 because of worsening starvation among older children.
Hunger gnaws at staff as well. Soboh said two nurses put themselves on IV drips to keep themselves going. "We are exhausted. We are dead in the shape of the living," she said.
The five children died in succession last Thursday, Saturday and Sunday.
Four of them, aged 4 months to 2 years, had suffered gastric arrest: Their stomachs shut down. The hospital no longer had the right nutrition supplies for them.
The fifth - 4 1/2-year-old Siwar - had alarmingly low potassium levels, a growing problem. She was so weak she could barely move her body. Medicine for potassium deficiency has largely run out across Gaza, Soboh said. The center had only a low-concentration potassium drip.
The little girl didn't respond. After three days in the ICU, she died Saturday.
"If we don't have potassium (supplies), we will see more deaths," she said.
In the Shati Refugee Camp in Gaza city, 2-year-old Yazan Abu Ful's mother, Naima, pulled off his clothes to show his emaciated body. His vertebrae, ribs and shoulder-blades jutted out. His buttocks were shriveled. His face was expressionless.
His father Mahmoud, who was also skinny, said they took him to the hospital several times. Doctors just say they should feed him. "I tell the doctors, 'You see for yourself, there is no food,'" he said,
Naima, who is pregnant, prepared a meal: Two eggplants they bought for $9 cut up and boiled in water. They will stretch out the pot of eggplant-water - not even a real soup - to last them a few days, they said. Several of Yazan's four older siblings also looked thin and drained.
Holding him in his lap, Mahmoud Abu Ful lifted Yazan's limp arms. The boy lies on the floor most of the day, too weak to play with his brothers. "If we leave him, he might just slip away from between our fingers, and we can't do anything."
Starvation takes the vulnerable first, experts say: children and adults with health conditions.
On Thursday, the bodies of an adult man and woman with signs of starvation were brought to Gaza City's Shifa Hospital, hospital director Mohammed Abu Selmia said. One suffered from diabetes, the other from a heart condition, but they showed severe deficiencies of nutrients, gastric arrest and anemia from malnutrition.
Many of the adults who have died had some sort of preexisting condition, like diabetes or heart or kidney trouble, worsened by malnutrition, Abu Selmia said. "These diseases don't kill if they have food and medicine," he said.
Israel cut off entry of food, medicine, fuel and other supplies completely to Gaza for 2.5 months starting in March, saying it aimed to pressure Hamas to release hostages. During that time, food largely ran out for aid groups and in marketplaces, and experts warned Gaza was headed for an outright famine.
In late May, Israel slightly eased the blockade. Since then, it has allowed in around 4,500 trucks for the U.N. and other aid groups to distribute, including 2,500 tons of baby food and high-calorie special food for children, the Israeli Foreign Ministry said Wednesday.
That is an average of 69 trucks a day, far below the 500-600 trucks a day the U.N. says are needed. The UN has been unable to distribute much of the aid because hungry crowds and gangs take most of it from its trucks. Separately, Israel has also backed the Gaza Humanitarian Foundation, which opened four centers distributing boxes of food supplies. Hundreds of Palestinians have been killed trying to reach the sites.
On Tuesday, David Mencer, spokesman for the Israeli Prime Minister's office, denied there is a "famine created by Israel" in Gaza and blamed Hamas for creating "man-made shortages" by looting aid trucks.
The UN denies Hamas siphons off significant quantities of aid. Humanitarian workers say Israel just needs to allow aid to flow in freely, saying looting stops whenever aid enters in large quantities.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Leucine Rich Bio Receives NABL Accreditation, Strengthening Diagnostic Credibility
Leucine Rich Bio Receives NABL Accreditation, Strengthening Diagnostic Credibility

Time of India

timean hour ago

  • Time of India

Leucine Rich Bio Receives NABL Accreditation, Strengthening Diagnostic Credibility

Bengaluru: South Asia-based microbiome-focused company Leucine Rich Bio has announced it has received accreditation from the National Accreditation Board for Testing and Calibration Laboratories (NABL), further validating the company's laboratory competence and operational reliability. The NABL accreditation , based on ISO/IEC 17025 standards, confirms that the company's testing processes meet stringent global benchmarks for technical accuracy and laboratory performance. Leucine Rich Bio claims to be India's only microbiome-dedicated organisation to hold both NABL and NABH accreditations, alongside ISO 9001:2015 and ISO 17025 certifications. While NABL and ISO 17025 affirm technical precision and reliable lab results, NABH accreditation reflects adherence to established clinical protocols and patient safety norms. The ISO 9001:2015 certification signifies robust quality management systems across the organisation. The company says these accreditations are critical to ensuring diagnostic accuracy and clinical reliability in microbiome testing , underscoring its commitment to high standards in personalised healthcare.

Moderna layoffs: U.S. Pharma giant announces massive job cuts, to have less than 5,000 employees, MRNA stocks sink
Moderna layoffs: U.S. Pharma giant announces massive job cuts, to have less than 5,000 employees, MRNA stocks sink

Time of India

timean hour ago

  • Time of India

Moderna layoffs: U.S. Pharma giant announces massive job cuts, to have less than 5,000 employees, MRNA stocks sink

Moderna said on Thursday it would trim roughly 10 per cent of its global workforce and have fewer than 5,000 employees by the end of the year, as the biotech accelerates its cost-cutting efforts amid declining sales of COVID-19 vaccines. The move, announced in an internal memo by CEO Stephane Bancel, is part of the company's previous plan to cut operating expenses by about $1.5 billion by 2027. "We've made significant progress by scaling down R&D as respiratory trials conclude, renegotiating supplier agreements, and reducing manufacturing costs," Bancel said in the memo. Explore courses from Top Institutes in Please select course: Select a Course Category MCA healthcare Leadership Technology Healthcare Project Management Data Science PGDM Public Policy Product Management CXO Artificial Intelligence Degree Digital Marketing Design Thinking Finance MBA Operations Management Data Analytics others Others Data Science Management Cybersecurity Skills you'll gain: Programming Proficiency Data Handling & Analysis Cybersecurity Awareness & Skills Artificial Intelligence & Machine Learning Duration: 24 Months Vellore Institute of Technology VIT Master of Computer Applications Starts on Aug 14, 2024 Get Details Moderna had said earlier this year it expects operating costs to be between $4.7 billion and $5 billion for 2027. The Cambridge, Massachusetts-based biotech has been banking on revenue from newer mRNA shots, including its experimental COVID-flu combination vaccine, to make up for falling sales of its COVID-19 shot and less-than-expected uptake of its respiratory syncytial virus vaccine. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Calcutta: 1 Trick to Reduce Belly Fat? Home Fitness Hack Shop Now Undo Moderna MRNA Stocks But investor concerns about the prospects of new shots and the changes in vaccine policy under U.S. Health Secretary and vaccine skeptic Robert F. Kennedy Jr. have led to a more than 20 per cent decline in Moderna's shares this year. Live Events The stock, which has lost more than 90 per cent of its value since the pandemic-era highs, was trading about 4 per cent down on Thursday. Moderna had said in May it did not expect regulatory approval for its combination shot until 2026, since the U.S. Food and Drug Administration asked for late-stage data showing the vaccine's efficacy against the flu. The company had previously hoped to launch the vaccine for the autumn respiratory disease season in 2025 or 2026. Bancel in the memo reiterated the company's target to have eight more approvals for its products in the next three years. FAQs Q1. Is Moderna laying off workforce? A1. Moderna said on Thursday it would trim roughly 10 per cent of its global workforce. Q2. What are Moderna's operating costs? A2. Moderna had said earlier this year it expects operating costs to be between $4.7 billion and $5 billion for 2027.

Moderna plans to lay off 10% of workforce to cut costs
Moderna plans to lay off 10% of workforce to cut costs

Time of India

timean hour ago

  • Time of India

Moderna plans to lay off 10% of workforce to cut costs

Moderna said on Thursday it would trim roughly 10% of its global workforce and have fewer than 5,000 employees by the end of the year, as the biotech accelerates its cost-cutting efforts amid declining sales of COVID-19 vaccines. The move, announced in an internal memo by CEO Stephane Bancel , is part of the company's previous plan to cut operating expenses by about $1.5 billion by 2027. Explore courses from Top Institutes in Please select course: Select a Course Category Operations Management Finance MCA Data Science Healthcare Public Policy Digital Marketing CXO Project Management PGDM Technology Artificial Intelligence Product Management healthcare Degree MBA Data Science others Management Leadership Data Analytics Cybersecurity Others Design Thinking Skills you'll gain: Quality Management & Lean Six Sigma Analytical Tools Supply Chain Management & Strategies Service Operations Management Duration: 10 Months IIM Lucknow IIML Executive Programme in Strategic Operations Management & Supply Chain Analytics Starts on Jan 27, 2024 Get Details "We've made significant progress by scaling down R&D as respiratory trials conclude, renegotiating supplier agreements, and reducing manufacturing costs," Bancel said in the memo. Moderna had said earlier this year it expects operating costs to be between $4.7 billion and $5 billion for 2027. The Cambridge, Massachusetts-based biotech has been banking on revenue from newer mRNA shots, including its experimental COVID-flu combination vaccine, to make up for falling sales of its COVID-19 shot and less-than-expected uptake of its respiratory syncytial virus vaccine. Live Events But investor concerns about the prospects of new shots and the changes in vaccine policy under U.S. Health Secretary and vaccine skeptic Robert F. Kennedy Jr. have led to a more than 20% decline in Moderna's shares this year. The stock, which has lost more than 90% of its value since the pandemic-era highs, was trading about 4% down on Thursday. Moderna had said in May it did not expect regulatory approval for its combination shot until 2026, since the U.S. Food and Drug Administration asked for late-stage data showing the vaccine's efficacy against the flu. The company had previously hoped to launch the vaccine for the autumn respiratory disease season in 2025 or 2026. Bancel in the memo reiterated the company's target to have eight more approvals for its products in the next three years.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store